KDM6A and chronic myelogenous leukemia, BCR-ABL1 positive: NGF did not rescue the cells from increased apoptotic cell death when KDM6A was knocked down (Figure S8B-C), indicating KDM6A intrinsically confers resistance to imatinib through TRKA in CML patients.